Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Clozapine-related Immunodeficiency Effect in Parkinsons Disease Patients

NCT06634641 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.

NCT NCT06634641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06634641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Clozapine-related Immunodeficiency Effect in Parkinsons Disease Patients
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2024
Completion date
September 30, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clozapine, immunodeficiency, parkinson's disease (pd), psychosis